This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Zeldes Haeggquist & Eck, LLP Announces Investigation Of Vocera Communications, Inc. Concerning Possible Violations Of Securities Laws

Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into Vocera Communications, Inc. (NYSE: VCRA), relating to potential violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 by certain of the Company’s officers and directors during the period between March 28, 2012 through May 2, 2013 (the “Class Period.”)

Founded in 2000 and headquartered in San Jose, California, Vocera provides mobile communication products and services to primarily healthcare markets. The Company’s products are deployed in hospitals and healthcare facilities, including large hospital systems, small and medium-sized local hospitals, and a small number of clinics, surgery centers, and aged-care facilities. In 2011, Vocera generated revenue of $79.5 million and a net loss of $2.5 million.

On March 28, 2012 Vocera conducted its IPO. The Company completed the IPO on April 2, 2012, having sold 5,000,000 shares and certain of its stockholders having sold 1,727,000 shares, including 877,500 shares for the underwriters' over-allotment option. The shares were sold at $16.00 per share for aggregate gross offering proceeds of $80.0 million to Vocera and $27.6 million to the selling stockholders.

Following the IPO, and during the Class Period, Vocera share prices increased significantly, climbing to over $32 per share in September 2012.

Then, on May 2, 2013, after the close of the market, Vocera shocked investors when it announced first quarter earnings and revenue that were significantly worse than expected. Full-year revenue and earnings forecasts were also sharply reduced. On a subsequent earnings call, management attributed the shortfall and weaker outlook to, among other factors, cost-cutting initiatives at hospitals due to healthcare reform.

On this news, on May 3, 2013, Vocera shares declined 37% to $12.15 per share from $19.38 per share, on unusually heavy volume of 6.7 million shares traded.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,832.33 +112.41 0.63%
S&P 500 2,095.95 +15.54 0.75%
NASDAQ 5,143.5040 +34.8380 0.68%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs